Valneva and Dynavax Collaborate to Develop COVID-19 Vaccine Post author:Sam Post published:April 23, 2020 Post category:Devices & Diagnostics Letter Dynavax used the adjuvant in its FDA-approved hepatitis B vaccine. Source: Devices & Diagnostics Letter You Might Also Like MHRA Temporarily Eases Some GMP Requirements April 23, 2020 UK Review Finds Better Device Data Might Prevent PIP-Type Safety Scares April 7, 2016 OIG: Many FDAers Still Wary to Air Concerns, Unclear on Dispute Process April 7, 2016
